Results 61 to 70 of about 761 (100)

Rapid symptomatic improvement with etrasimod in ulcerative colitis: a post-hoc analysis of the ELEVATE UC program. [PDF]

Inflamm Bowel Dis
Dubinsky MC, Chaparro M, Irving PM, Hur P, Sidhu S, Woolcott JC, Wang W, Goetsch M, Torres J, Panaccione R.   +9 more
europepmc   +1 more source

Comprehensive analysis of etrasimod-related adverse events based on the FDA Adverse Event Reporting System database. [PDF]

Indian J Pharmacol
Zhou ZR, Zhang WJ, Zhao XY, Shen Y, Zhan Q, Sun J.   +5 more
europepmc   +1 more source

Safety and efficacy of etrasimod in ulcerative colitis: Evidence from a meta-analysis. [PDF]

Medicine (Baltimore)
Alla D, Appala S, Meyur S, Ganguru SL, Ramsundar R, Gupta S, Sriramaneni PK, Boppana G, Cheguru SR, Emmanuel NW, Bolineni M, Rohan RP, Chowdhary R.   +12 more
europepmc   +1 more source

Asian Pacific Association of Gastroenterology (APAGE) Clinical Practice Guidelines on the Use of Small Molecules and IL-23 p19 Inhibitors in Ulcerative Colitis and Crohn's Disease. [PDF]

J Gastroenterol Hepatol
Ooi CJ, Ling KL, Limsrivilai J, Wei SC, Mak JWY, Kobayashi T, Dang LM, Leong RW, Lin H, Weng MT, Ong WC, Ahuja V, Aniwan S, Hokari R, Lee WJJ, Leow AH, Leung WK, Lim WC, Makharia G, Matsuoka K, Mustaffa N, Ng SC, Philip M, Pisespongsa P, Ali RAR, Ran ZH, Simadibrata M, Sollano J, Tan M, Viet HD, Wan Ibrahim NR, Wu KC, Ye BD, Hilmi I, Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease Committee and Asian Education Network in IBD (AEN‐IBD).   +34 more
europepmc   +1 more source

Efficacy of Biological and Steroid Therapies in Adolescent and Adult Patients With Eosinophilic Esophagitis: A Systematic Review and Network Meta-Analysis With Meta-Regression. [PDF]

Clin Gastroenterol Hepatol
Al Hayek M, Lucendo AJ, Savarino EV, Barberio B, Gyawali CP, Chan WW, Visaggi P, Najah Q, Yadlapati R, McCoul ED, Elhadi M, Laine L.   +11 more
europepmc   +1 more source

Synthesis of new etrasimod derivatives and evaluation of their antibacterial activity using Caenorhabditis elegans as an infection model

Antimicrobial resistance (AMR) is a growing global health concern, and the development of new antibacterial agents is crucial to addressing this issue. Commercial antibiotics are not as effective as they used to be to combat infections.
Venäläinen Birgitta
core  

Machine Learning-Driven Drug Repurposing for KRAS G12C and KRAS G12D Inhibition. [PDF]

ACS Omega
Fuschi G, Germain JS, Bebensee D, Moawad C, Aladysheva A, Mohamed A, Brooks BR, Savai R, Elwakeel E, Amin M.   +9 more
europepmc   +1 more source

Cost-Effectiveness Analysis of Etrasimod Compared With Biologic Therapies for the Treatment of Patients with Moderately-to-Severely Active Ulcerative Colitis in Spain. [PDF]

Pharmacoecon Open
Rodríguez-Lago I, Muñoz Núñez F, Lucendo AJ, De Lossada Juste A, Cabez A, de la Cuadra-Grande A, Oyagüez I, Monte-Boquet E.   +7 more
europepmc   +1 more source

Autotaxin Induces S1P/S1PR1 Signaling to Affect Th17/Treg Cell Balance and Exacerbate Intestinal Inflammation in Colitis. [PDF]

Int J Mol Sci
Xiao S, Peng K, Li C, Long Y, Yu H, Xia S, Tan Q, Yu Q.   +7 more
europepmc   +1 more source

Efficacy and Safety of Etrasimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Baseline Modified Mayo Score: A Post Hoc Analysis From the Phase 3 ELEVATE UC Clinical Program. [PDF]

Inflamm Bowel Dis
Sands BE, Dubinsky MC, Kotze PG, Vermeire S, Panaccione R, Long MD, Woolcott JC, Wu J, McDonnell A, Goetsch M, Bananis E, Yarur AJ.   +11 more
europepmc   +1 more source